(10) showed a significantly lower SUVmax in PCa patients receiving RP with an immunoreactive score (IRS) smaller than 2 or a PSMA staining in less than 50% of the cancer cells in pathological specimens. The gene discussed is FOLH1; the disease is posterior cortical atrophy.